Our Customers

BioSpherix proudly serves a diverse global clientele, spanning continents and a multitude of disciplines. Our innovative technologies have been cited in over 5,000 peer-reviewed publications, showcasing our commitment to advancing cell-based research worldwide. Join researchers across the globe in harnessing our expertise to drive groundbreaking discoveries and transformative healthcare solutions.

See how other researchers in your field are using our systems.

Spin the globe to see where Xvivo Systems® are in use today!

{

“I have used Biospherix small animal oxygen chambers in my research for over a decade, and they have served me exceptionally well. The chambers are reliable and well designed, even with long-term, routine use. Just as importantly, customer and technical support has always been prompt, friendly, and effective whenever I’ve needed assistance. Biospherix has been a dependable partner in my work.”

Silke Becker, PhD
Assistant Professor of Ophthalmology
University of Pittsburgh
{

We first contacted the team when we were setting up our GMP facility in Bangkok, Thailand … The system is incredibly straight forward to learn and get comfortable with … The best part about the system is how well it maintains sterility, which ensures that we have a high rate of batch compliance. The team are also very responsive to any inquiries despite the time difference, and over the years we have built a great relationship with them.

Rahul Pawa
Austrianova
{

The BioSpherix System provides an operational advantage through reduced processing times and less time spent gowning-up.

Australian Red Cross
{

We provide a constant physiologic environment with the Xvivo, so we’re hitting the cells with only defined components and we know exactly what we’re changing. We put the cell at the center and it works.

Michael Gilkey
CEO
Trailhead Biosystems
{

If you could look into the future, this would be the future of organ transplantation…This is much more elegant and much safer. This is like a new chapter in medicine.

Dr. Richard Pearl
Surgeon-in-Chief
University of Illinois College of Medicine at Peoria
{

The Xvivo barrier isolator system for cells was the answer to our prayers. Their technology allowed us to safely build a new trachea for our patient and virtually eliminated the risk of contamination.

Dr. Mark Holterman
Professor of Surgery and Pediatrics
University of Illinois College of Medicine at Peoria
{

The enhanced flexibility of the system allows me to have reduced staffing and staff flexibility. Technicians efficiently move back and forth within reduced classification suites. In addition, the enhanced reagent flow in and out of the operating space is a plus for our multiple trials. Another advantage of the technology is our ability to separate our processes – if we make changes to one unit the rest of them are unchanged.

David Courtman, PhD
OHRI
{

Bristol-Myers Squibb selected the BioSpherix Isolator for the soft, clear design of the isolator fact and its tactile gloves. We also especially liked the versatility provided by the modular units that made customizing modules of different configurations very easy. At FAT, the team was impressed with the ability of the Isolator to rapidly clear particle counts.

Sr. Process Engineer
Bristol-Myers Squibb
{

The other big advantage is between BioSpherix isolators vs. traditional stainless steel isolators, is that I can rearrange these modules however I want. That is a huge advantage when developing a strategy for cell therapy replacement. There’s a lot we don’t know, so modularity is key.

Budd Tucker PhD
Director
Steven W. Dezii Translational Vision Facility
{

Thank you, BioSpherix, for the good equipment you have provided us. It gave us the necessary tools to study MSC in their adequate environments (Normoxia, Hypoxia and Anoxia). Well done!

Adrian Moya PhD
University of Miami